Brad D. Constant

Pediatric Gastroenterology

13123 E 16th Ave
Aurora, CO 80045

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Best practices for prior authorization in pediatric inflammatory bowel disease: A practical multidisciplinary roadmap.

Best practices for prior authorization in pediatric inflammatory bowel disease: A practical multidisciplinary roadmap.

Journal: Journal of pediatric gastroenterology and nutrition

Published: April 22, 2026

The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in Children.

The Safety and Effectiveness of Early Anti-Tumor-Necrosis-Factor Therapy for Penetrating Crohn's Disease Complications in Children.

Journal: The American journal of gastroenterology

Published: February 23, 2026

Local prevalence and management of Janus kinase inhibitor-induced acne among adolescents with inflammatory bowel disease.

Local prevalence and management of Janus kinase inhibitor-induced acne among adolescents with inflammatory bowel disease.

Journal: Crohn's & colitis 360

Published: July 30, 2025

Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy.

Postoperative Outcomes in Tofacitinib-Treated Patients With Acute Severe Ulcerative Colitis Undergoing Colectomy.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: July 22, 2024

National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease.

National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease.

Journal: JPGN reports

Published: May 02, 2024

Insurer-Mandated Medication Utilization Barriers are Associated With Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An Inflammatory Bowel Disease Partners Survey.

Insurer-Mandated Medication Utilization Barriers are Associated With Decreased Insurance Satisfaction and Adverse Clinical Outcomes: An Inflammatory Bowel Disease Partners Survey.

Journal: The American journal of gastroenterology

Published: December 17, 2023

Ustekinumab is safe and effective in pediatric patients with Crohn's disease.

Ustekinumab is safe and effective in pediatric patients with Crohn's disease.

Journal: Journal of pediatric gastroenterology and nutrition

Published: December 08, 2023

The PA System: Is Prior Authorization for Dose Escalation of IBD Biologic Therapy a Tolerable Alternative or a Perpetual Annoyance?

The PA System: Is Prior Authorization for Dose Escalation of IBD Biologic Therapy a Tolerable Alternative or a Perpetual Annoyance?

Journal: Digestive diseases and sciences

Published: August 01, 2023

Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey.

Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 27, 2023

Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.

Incidence, Prevalence, and Racial and Ethnic Distribution of Inflammatory Bowel Disease in the United States.

Journal: Gastroenterology

Published: February 09, 2023

Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases.

Development and Validation of Claims-Based Definitions to Identify Incident and Prevalent Inflammatory Bowel Disease in Administrative Healthcare Databases.

Journal: Inflammatory bowel diseases

Published: December 27, 2022

Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis.

Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis.

Journal: Journal of pediatric gastroenterology and nutrition

Published: September 19, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026